This randomized trial evaluates diagnostic instruments for bipolar disorder, suggesting improvements in clinical management.
Bipolar disorder, a chronic and recurrent psychiatric illness, is characterized by substantial diagnostic challenges and heterogeneous clinical manifestations.Because patients often present during depressive episodes and may not recognize previous hypomanic symptoms, standardized assessment instruments are crucial in improving diagnostic accuracy and guiding clinical management.Clinician-rated scales provide reliable measures of symptom severity, whereas self-report instruments facilitate the identification of bipolar spectrum disorders in various clinical settings.However, no single instrument is sufficient for obtaining a definite diagnosis, and each has distinct strengths and limitations depending on the target population and clinical purpose.Recent international guidelines emphasize measurementbased care and recommend the routine use of validated assessment tools to monitor symptom progression, treatment response, functional recovery, and patient-reported outcomes throughout the course of illness.Integrating standardized rating scales with comprehensive clinical evaluation and emerging digital technologies may facilitate early diagnosis, optimize treatment decisions, and improve long-term clinical and functional outcomes in patients with bipolar disorder.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: